Zylox-Tonbridge and GL Capital will jointly invest approximately HK$1.482 billion in LifeTech Scientific for a 16.7% stake. Zylox-Tonbridge will invest HK$889 million and intends to pursue a potential merger with LifeTech.
ENDATA